Lombard Odier Asset Management (Europe)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,313
Closed -$215K 397
2017
Q3
$215K Hold
2,313
0.01% 382
2017
Q2
$210K Hold
2,313
0.01% 379
2017
Q1
$203K Buy
+2,313
New +$203K 0.01% 378